Pharmacy Staff Interventions in a Medical Center Hematology–Oncology Service

Waddell, J. Aubrey; Solimando, Dominic A.; Strickland, William R.; Smith, Byron D.; Wray, Melissa K.

doi:10.1016/s1086-5802(16)30346-1

Cited by 28 publications

(20 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Corresponding well with our study, the majority of the interventions demonstrated in that study was provision of drug information/ consultation to other health care providers. 25 Further, an intervention study by Wong and Gray in haematology-oncology clinics in Virginia providing ambulatory cancer services for adults and children demonstrated less number of interventions per day, half as much, as opposed to our study. 2 Wong and Gray found patient counselling and therapeutic recommendations (i.e.…”

Section: Discussioncontrasting

confidence: 95%

“…As with our study, some studies documenting interventions for children and adult patients undertaken by haematology-oncology pharmacy staff also demonstrated improper dosing as the most common drug related problem. 25,37 In addition, a study using multidisciplinary health care professionals for detecting medication errors in an adult haematologyoncology unit in Spain demonstrated a similar pattern where errors in dosing being accountable for the majority of the errors. 32 Interestingly, this Spanish study showed that more than two-thirds of the errors were detected by pharmacists while the remaining cases were intercepted by medical and nursing staff.…”

Section: Discussionmentioning

confidence: 99%

“…A considerably high rate of acceptance to pharmacists' interventions in this highrisk area has also been reported in some studies. 2,25,26,32 The high acceptance rate is the positive indicator that pharmacists are well accepted and considered as reliable source of information by other health care providers.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Pharmacists’ Interventions in A Paediatric Haematology-Oncology Pharmacy: Do They Matter to Minimise Medication Misadventure?

Ramadaniati

Lee

Hughes

et al. 2016

Indones J Clin Pharm

View full text Add to dashboard Cite

Paediatric patients with cancer are a high-risk patient population for medication misadventures. This study aimed to document and evaluate the role of pharmacists' interventions during dispensing-related activities in minimising the occurrence of medication misadventure in haematology-oncology patients. The primary investigator observed and documented all clinical interventions during dispensing-related activities performed by clinical pharmacists in a haematology-oncology pharmacy during 33-day. A total of 359 interventions were performed for 1028 patients. The rates of intervention were 20.04 per 100 medication orders and 34.92 per 100 patients. Provision of drug information was the most common interventions constituting more than three quarters of all interventions. According to therapeutic groups, cytotoxic antineoplastics made up more than half of all interventions. Of all interventions, 22 involved recommendations leading to changes in patients' treatment (active interventions), and all recommendations were accepted. The top three medication errors were due to inappropriate dosing, labelling error, and unfulfilled indication. Clinical pharmacists' intervention during dispensing in a paediatric haematology-oncology pharmacy improved medication safety and patient care by minimising the incidence of medication misadventures.

show abstract

Section: Discussioncontrasting

confidence: 95%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacists’ Interventions in A Paediatric Haematology-Oncology Pharmacy: Do They Matter to Minimise Medication Misadventure?

Ramadaniati

Lee

Hughes

et al. 2016

Indones J Clin Pharm

View full text Add to dashboard Cite

show abstract

“…Some studies used the raw pharmaceutical cost of a medication to estimate the cost of an error5 6 18–20 23 30 and this was the only single direct cost involved in the calculation. Others expanded on this basic methodology, adding in additional direct costs related to the cost of a hospital stay, laboratory tests and labour costs.…”

Section: Resultsmentioning

confidence: 99%

“…A number of studies9 18 19 23 28 30 attempted to calculate the cost of an ME indirectly by estimating the cost reduction from preventing errors following an intervention. The cost of the MEs calculated in this way varied depending on the nature and effectiveness of the intervention in a particular care context.…”

Section: Discussionmentioning

confidence: 99%

A systematic review of approaches for calculating the cost of medication errors

et al. 2016

View full text Add to dashboard Cite

Ambulatory care hematology/oncology pharmacy services: A comprehensive review by the Saudi Oncology Pharmacy Assembly

Alsuhebany,

Alkhudair,

Alzahrani

et al. 2024

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Saudi Vision 2030 has driven significant changes in ambulatory care pharmacy services in the Kingdom of Saudi Arabia (KSA), transitioning pharmaceutical care from inpatient to outpatient settings. With a growing need to address non‐communicable diseases, particularly cancer, ambulatory care oncology pharmacy services are of paramount importance. This study aims to evaluate the potential benefits and challenges of establishing such services in the KSA and offers recommendations for clinical pharmacists. A comprehensive literature search was conducted using PubMed, MEDLINE, EMBASE, and Google Scholar, encompassing research from inception to September 2023. The search focused on English language studies related to ambulatory care oncology/hematology pharmacy services. Among the 1351 studies found, those assessing the impact of clinical pharmacists on patient outcomes in outpatient oncology clinics were included. The review of the literature highlights the substantial impact of clinical pharmacists in outpatient hematology/oncology settings. A selection of several studies revealed their role in improving patient care, reducing health care costs, and enhancing treatment outcomes. Notable findings include a high acceptance rate of pharmacist interventions with significant cost savings, increased pharmacist involvement in patient encounters, and reduced emergency department visits and inpatient admissions due to pharmacist interventions. These results showed the valuable contributions of clinical pharmacists in the international outpatient oncology setting. Establishing ambulatory care hematology/oncology pharmacy services in Saudi Arabia is critical, considering the rising cancer burden. The value of specialized oncology clinical pharmacists in the outpatient setting is emphasized by various studies conducted in the United States. This review proposes a framework for patient‐centered oncology practices, serving as a valuable resource for the strategic development of ambulatory care oncology pharmacy services in Saudi Arabia. These efforts align with Saudi Vision 2030's broader goals of enhancing health care quality and patient care.

show abstract

Pharmacy Staff Interventions in a Medical Center Hematology–Oncology Service

Cited by 28 publications

References 6 publications

Pharmacists’ Interventions in A Paediatric Haematology-Oncology Pharmacy: Do They Matter to Minimise Medication Misadventure?

Pharmacists’ Interventions in A Paediatric Haematology-Oncology Pharmacy: Do They Matter to Minimise Medication Misadventure?

A systematic review of approaches for calculating the cost of medication errors

Ambulatory care hematology/oncology pharmacy services: A comprehensive review by the Saudi Oncology Pharmacy Assembly

Contact Info

Product

Resources

About